Most sold healthcare stocks in Q2 2019
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2019, measured as net reductions in reported share positions from Q1 2019 into Q2 2019. Notable reductions at the top of this list include MODERNA INC (MRNA), NOVARTIS AG-SPONSORED ADR (NVS), BAXTER INTERNATIONAL INC (BAX), ELI LILLY & CO (LLY). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRNA | MODERNA INC | -8,188,608 | -$215.05K | 1 | 0 | 1 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | -6,101,343 | -$584.83K | 0 | 4 | 3 | 0 | 8 |
| BAX | BAXTER INTERNATIONAL INC | -5,046,485 | -$396.32K | 0 | 0 | 4 | 0 | 5 |
| LLY | ELI LILLY & CO | -4,245,919 | -$775.74K | 0 | 1 | 3 | 0 | 4 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -2,342,244 | -$218.65K | 0 | 1 | 2 | 0 | 3 |
| MD | PEDIATRIX MEDICAL GROUP INC | -2,238,641 | -$62.29K | 0 | 1 | 0 | 1 | 1 |
| CVS | CVS HEALTH CORP | -1,887,874 | -$79.99K | 1 | 4 | 4 | 0 | 9 |
| EHC | ENCOMPASS HEALTH CORP | -1,130,900 | -$60.45K | 0 | 1 | 1 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | -963,997 | -$209.37K | 2 | 2 | 6 | 1 | 12 |
| DXCM | DEXCOM INC | -961,198 | -$105.23K | 0 | 0 | 1 | 0 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -845,285 | -$4.93K | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -684,948 | $24.13K | 0 | 1 | 1 | 0 | 2 |
| NTRA | NATERA INC | -674,200 | -$13.22K | 0 | 0 | 1 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | -627,891 | -$34.71K | 0 | 0 | 1 | 0 | 1 |
| STAA | STAAR SURGICAL CO | -554,300 | -$19.87K | 0 | 0 | 1 | 0 | 1 |
| PTCT | PTC THERAPEUTICS INC | -538,240 | -$17.54K | 0 | 0 | 1 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | -521,532 | -$30.61K | 0 | 1 | 2 | 0 | 5 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -520,902 | $22.07K | 0 | 0 | 2 | 0 | 2 |
| RGNX | REGENXBIO INC | -519,300 | -$31.84K | 0 | 0 | 1 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | -514,902 | -$75.61K | 0 | 1 | 1 | 0 | 3 |
| XRAY | DENTSPLY SIRONA INC | -505,682 | -$11.23K | 1 | 0 | 1 | 0 | 4 |
| MCK | MCKESSON CORP | -477,246 | $127.08K | 0 | 1 | 4 | 0 | 6 |
| HCA | HCA HEALTHCARE INC | -445,000 | -$56.06K | 0 | 0 | 1 | 0 | 2 |
| MGNX | MACROGENICS INC | -399,300 | -$7.61K | 0 | 0 | 1 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -377,500 | -$15.64K | 0 | 0 | 1 | 0 | 1 |
| VCEL | VERICEL CORP | -361,092 | -$6.32K | 0 | 0 | 0 | 1 | 0 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -357,453 | -$4.84K | 0 | 0 | 0 | 1 | 0 |
| VCYT | VERACYTE INC | -351,720 | $3.63K | 0 | 1 | 1 | 0 | 2 |
| AMRX | AMNEAL PHARMACEUTICALS INC | -315,700 | -$4.97K | 0 | 0 | 1 | 0 | 1 |
| MNKD | MANNKIND CORP | -305,954 | -$603 | 0 | 0 | 0 | 1 | 0 |
| ALGN | ALIGN TECHNOLOGY INC | -301,964 | -$163.78K | 0 | 2 | 5 | 0 | 7 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -297,831 | -$40.13K | 1 | 1 | 1 | 0 | 3 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -297,400 | -$1.42K | 0 | 0 | 1 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -296,384 | -$4.20K | 0 | 0 | 2 | 0 | 4 |
| SGMO | SANGAMO THERAPEUTICS INC | -278,400 | -$1.89K | 0 | 0 | 1 | 0 | 1 |
| ARAY | ACCURAY INC | -274,723 | -$5.90K | 0 | 0 | 1 | 0 | 1 |
| AMGN | AMGEN INC | -272,930 | -$75.99K | 0 | 3 | 3 | 0 | 6 |
| UNH | UNITEDHEALTH GROUP INC | -257,727 | -$135.65K | 0 | 9 | 4 | 1 | 13 |
| MTNB | MATINAS BIOPHARMA HOLDINGS I | -253,000 | -$276 | 0 | 0 | 0 | 1 | 0 |
| CRL | CHARLES RIVER LABORATORIES | -252,135 | -$44.93K | 0 | 0 | 2 | 0 | 2 |
| DHR | DANAHER CORP | -243,625 | $129.87K | 0 | 1 | 4 | 0 | 7 |
| NBIX | NEUROCRINE BIOSCIENCES INC | -212,700 | -$18.80K | 0 | 0 | 1 | 0 | 1 |
| RDNT | RADNET INC | -203,300 | -$217 | 0 | 0 | 1 | 0 | 1 |
| EVH | EVOLENT HEALTH INC - A | -195,499 | -$2.46K | 0 | 0 | 0 | 1 | 0 |
| IDXX | IDEXX LABORATORIES INC | -193,328 | $234.51K | 0 | 2 | 1 | 0 | 5 |
| BLFS | BIOLIFE SOLUTIONS INC | -189,300 | -$3.50K | 0 | 0 | 1 | 0 | 2 |
| NVRO | NEVRO CORP | -185,914 | -$11.33K | 0 | 0 | 1 | 1 | 1 |
| AMED | AMEDISYS INC | -184,601 | -$22.76K | 0 | 0 | 1 | 0 | 1 |
| CVM | CEL-SCI CORP | -177,600 | -$629 | 0 | 0 | 0 | 1 | 0 |
| KALV | KALVISTA PHARMACEUTICALS INC | -159,929 | -$4.58K | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q2 2019
What are the most sold Healthcare stocks in Q2 2019?
The most sold healthcare stocks in Q2 2019 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q1 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2019?
Among the managers we track, net reductions were largest in companies such as MODERNA INC (MRNA), NOVARTIS AG-SPONSORED ADR (NVS), BAXTER INTERNATIONAL INC (BAX), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2019).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.